• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者的纤维蛋白溶解——纤溶酶原激活物抑制剂与纤维蛋白溶解系统其他成分的比较

Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.

作者信息

Nicoloso G, Hauert J, Kruithof E K, Van Melle G, Bachmann F

机构信息

Département de Médecine Interne, CHUV, Lausanne, Switzerland.

出版信息

Thromb Haemost. 1988 Apr 8;59(2):299-303.

PMID:3133812
Abstract

We analyzed fibrinolytic parameters in 20 healthy men and 20 healthy women, aged from 25 to 59, before and after 10 and 20 min venous occlusion. The 10 min post-occlusion fibrinolytic activity measured directly in diluted unfractionated plasma by a highly sensitive 125I-fibrin plate assay correlated well with the activity of euglobulins determined by the classical fibrin plate assay (r = 0.729), but pre-stasis activities determined with these two methods did not correlate (r = 0.084). The enhancement of fibrinolytic activity after venous occlusion was mainly due to an increase of t-PA in the occluded vessels (4-fold increase t-PA antigen after 10 min and 8-fold after 20 min venous occlusion). Plasminogen activator inhibitor (PAI) activity and plasminogen activator inhibitor 1 (PAI-1)1 antigen levels at rest showed considerable dispersion ranging from 1.9 to 12.4 U/ml, respectively 6.9 to 77 ng/ml. A significant increase of PAI-1 antigen levels was observed after 10 and 20 min venous occlusion. At rest no correlation was found between PAI activity or PAI-1 antigen levels and the fibrinolytic activity measured by 125I-FPA. However, a high level of PAI-1 at rest was associated with a high prestasis antigen level of t-PA and a low fibrinolytic response after 10 min of venous stasis. Since the fibrinolytic response inversely correlated with PAI activity at rest, we conclude that its degree depends mainly on the presence of free PAI.

摘要

我们分析了20名年龄在25至59岁之间的健康男性和20名健康女性在静脉阻塞10分钟和20分钟前后的纤溶参数。通过高灵敏度的125I - 纤维蛋白平板法直接在稀释的未分级血浆中测量的阻塞后10分钟纤溶活性与经典纤维蛋白平板法测定的优球蛋白活性相关性良好(r = 0.729),但用这两种方法测定的阻塞前活性不相关(r = 0.084)。静脉阻塞后纤溶活性的增强主要是由于阻塞血管中组织型纤溶酶原激活物(t - PA)增加(静脉阻塞10分钟后t - PA抗原增加4倍,20分钟后增加8倍)。静息时纤溶酶原激活物抑制剂(PAI)活性和纤溶酶原激活物抑制剂1(PAI - 1)抗原水平显示出相当大的离散度,分别为1.9至12.4 U/ml和6.9至77 ng/ml。静脉阻塞10分钟和20分钟后观察到PAI - 1抗原水平显著增加。静息时,未发现PAI活性或PAI - 1抗原水平与通过125I - FPA测量的纤溶活性之间存在相关性。然而,静息时高水平的PAI - 1与阻塞前高水平的t - PA抗原以及静脉淤滞10分钟后的低纤溶反应相关。由于纤溶反应与静息时的PAI活性呈负相关,我们得出结论,其程度主要取决于游离PAI的存在。

相似文献

1
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.正常受试者的纤维蛋白溶解——纤溶酶原激活物抑制剂与纤维蛋白溶解系统其他成分的比较
Thromb Haemost. 1988 Apr 8;59(2):299-303.
2
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
3
Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.正常男性和女性体内的纤溶酶原激活剂组织型纤溶酶原激活剂(t-PA)、尿激酶型纤溶酶原激活剂(u-PA)及其抑制剂(PAI) 。
Thromb Haemost. 1991 Nov 1;66(5):581-5.
4
Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.有特发性深静脉血栓形成和/或肺栓塞病史患者的纤溶功能减退。
Thromb Haemost. 1992 Apr 2;67(4):397-401.
5
Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.健康受试者对静脉闭塞的纤溶反应的可重复性。
Thromb Haemost. 1995 Mar;73(3):453-7.
6
Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.妊娠和产褥期静脉闭塞后的组织型纤溶酶原激活剂
Thromb Haemost. 1993 Sep 1;70(3):486-90.
7
Diurnal variation of the fibrinolytic system.纤维蛋白溶解系统的昼夜变化。
Thromb Haemost. 1988 Jun 16;59(3):495-9.
8
Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
Thromb Haemost. 1987 Oct 28;58(3):843-9.
9
Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.不明原因早期复发性流产女性的血浆纤溶激活剂及其抑制剂
J Lab Clin Med. 1993 Nov;122(5):606-15.
10
[Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].[纤维蛋白溶解系统参数测量中的问题:组织型纤溶酶原激活物和纤溶酶原激活物抑制剂的昼夜节律]
Klin Wochenschr. 1988;66 Suppl 12:62-7.

引用本文的文献

1
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis.导管定向溶栓与全身溶栓治疗肺栓塞的比较:一项系统评价和荟萃分析。
J Thromb Thrombolysis. 2022 Feb;53(2):454-466. doi: 10.1007/s11239-021-02556-7. Epub 2021 Aug 31.
2
Coagulation complications following trauma.创伤后的凝血并发症。
Mil Med Res. 2016 Nov 22;3:35. doi: 10.1186/s40779-016-0105-2. eCollection 2016.
3
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.
组织型纤溶酶原激活剂是中枢神经系统中的一种神经保护剂。
Front Cell Neurosci. 2015 Aug 17;9:304. doi: 10.3389/fncel.2015.00304. eCollection 2015.
4
The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.间歇性气动压迫的纤溶作用:纤溶增强的机制
Ann Surg. 1997 Sep;226(3):306-13; discussion 313-4. doi: 10.1097/00000658-199709000-00010.
5
The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.人胚胎-胎儿骨形成过程中尿激酶型纤溶酶原激活物(u-PA)及其抑制剂(PAI-1):一项免疫组织化学研究。
Anat Embryol (Berl). 1995 Oct;192(4):363-8. doi: 10.1007/BF00710105.
6
Prothrombotic abnormalities in inflammatory bowel disease.炎症性肠病中的血栓前状态异常。
Dig Dis Sci. 1989 Jul;34(7):1089-93. doi: 10.1007/BF01536380.